Analyst Ratings for Reviva Pharmaceuticals (RVPH)
RVPH Rating Summary
RVPH Price Target Summary
- Highest: $7.00 (Benchmark)
- Lowest: $2.00 (Chardan)
- Average: $4.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.33 (+1138.1%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Avg. $ Target:
$4.33 (+1138.1%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/8/2026 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
0.78 (0.35) |
-55.13% | Details |
| 3/5/2026 | D. Boral Capital | Jason Kolbert | Downgrade | Hold (Buy) |
N/A (N/A) |
0.24 (0.35) |
45.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
